<DOC>
	<DOCNO>NCT00977522</DOCNO>
	<brief_summary>This study examine efficacy PF-03463275 compare placebo treat negative symptom schizophrenia add ongoing antipsychotic treatment stable outpatient schizophrenia .</brief_summary>
	<brief_title>A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia</brief_title>
	<detailed_description>The study terminate August 25 , 2010 study 's scientific validity could longer support . The decision terminate trial base safety concern .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Subjects must current diagnosis schizophrenia paranoid ( 295.30 ) , disorganize ( 295.10 ) , undifferentiated ( 295.90 ) subtype residual phase . Subjects must ongoing maintenance antipsychotic monotherapy risperidone , olanzapine , quetiapine , ziprasidone , paliperidone , aripiprazole . Subjects must stable medication treatment regimen least 2 month . Evidence stable symptomatology least 3 month . Female subject pregnant breastfeeding . Subjects evidence history clinically significant medical condition would increase risk could interfere interpretation trial result . Subjects DSM IV define psychoactive substance dependence ( include alcohol exclude nicotine caffeine dependence ) within 12 month screen substance abuse within 3 month prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>schizophrenia negative symptom adjunctive</keyword>
</DOC>